Back
Nuvalent, Inc. Vs. Protagenic Therapeutics, Inc. Industry Stock Comparison
Sell
41
NUVL
Nuvalent, Inc.
Last Price:
$100.16
Seasonality Move:
-11.13%
Sell
35
PTIX
Protagenic Therapeutics, Inc.
Last Price:
$1.35
Seasonality Move:
56.89%
Sell
41
Nuvalent, Inc. (NUVL)
is a Sell
Is Nuvalent, Inc. a Buy, Sell or Hold?
-
The current Nuvalent, Inc. [NUVL] share price is $101.76. The Score for NUVL is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
NUVL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Protagenic Therapeutics, Inc. (PTIX)
is a Sell
Is Protagenic Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Protagenic Therapeutics, Inc. [PTIX] share price is $1.49. The Score for PTIX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
PTIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NUVL Stock Price Chart
What is Nuvalent, Inc.'s stock price today?
-
The Nuvalent, Inc. share price today is $101.76Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NUVL is experiencing selling pressure, which indicates risk of future bearish movement.
PTIX Stock Price Chart
What is Protagenic Therapeutics, Inc.'s stock price today?
-
The Protagenic Therapeutics, Inc. share price today is $1.49Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTIX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NUVL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 45.86 | Sell |
| Chaikin Money Flow: | -130269 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.29 - 108.23) | Sell |
| Bollinger Bands (100): | (78.64 - 102.74) | Buy |
PTIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 43.16 | Sell |
| Chaikin Money Flow: | 54042 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 2) | Sell |
| Bollinger Bands (100): | (1.86 - 3.6) | Sell |
NUVL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 103.58 | Sell |
| 20-day SMA: | 105.02 | Sell |
| 50-day SMA: | 101.53 | Buy |
| 200-day SMA: | 83.07 | Buy |
| 8-day EMA: | 103.89 | Sell |
| 20-day EMA: | 104.13 | Sell |
| 50-day EMA: | 100.42 | Buy |
| 200-day EMA: | 88.17 | Buy |
PTIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.29 | Buy |
| 20-day SMA: | 1.53 | Sell |
| 50-day SMA: | 2.05 | Sell |
| 200-day SMA: | 3.2 | Sell |
| 8-day EMA: | 1.36 | Buy |
| 20-day EMA: | 1.54 | Sell |
| 50-day EMA: | 2 | Sell |
| 200-day EMA: | 3.64 | Sell |
Nuvalent, Inc. Earnings Growth & NUVL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.00 per share.
Protagenic Therapeutics, Inc. Earnings Growth & PTIX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nuvalent, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagenic Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||